{"url_path":"/sec/vtvt/8-k/2026-06-29/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/1641489/0001641489-26-000024-index.html","accession_number":"0001641489-26-000024","cik":"0001641489","ticker":"VTVT","issuer_name":"vTv Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1641489/0001641489-26-000024-index.html","primary_entity_key":"0001641489","primary_entity_name":"vTv Therapeutics Inc."},"word_count":245,"has_tables":true,"body_markdown":"Item 5.07    Submission of Matters to a Vote of Security Holders.\n\nOn June 26, 2026, vTv Therapeutics Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below:\n\n(1)Based on the following results of the voting, the Company’s stockholders elected the nominees listed below to the Company’s Board of Directors, each to serve for a term to expire at the Company’s 2027 annual meeting of stockholders or until their successors are duly elected and qualified:\n\nDirector Nominee\nFor\n\nWithheld\nBroker Non Votes\n\nSrinivas Akkaraju\n720,9631,938,192310,535\n\nRaymond Cheong\n729,4891,929,666310,535\n\nFahed Al Marzooqi2,395,229263,926310,535\n\nRichard S. Nelson\n2,395,013264,142310,535\n\nAnne Phillips\n905,9381,753,217310,535\n\nPaul Sekhri\n905,3251,753,830310,535\n\nDaniel K. Spiegelman\n774,2441,884,911310,535\n\n(2)The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified based on the following results of the voting:\n\nFor\nAgainstAbstainBroker Non Votes\n\n2,964,8691,9522,8690\n\n(3)The Company’s stockholders voted on a nonbinding advisory basis on the compensation paid to the Company’s named executive officers as follows:\n\nFor\nAgainstAbstainBroker Non Votes\n\n686,5355,2911,967,329310,535\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.\n\nVTV THERAPEUTICS INC.\n\nBy:\n/s/ Michael Tung\n\nName:\nMichael Tung\n\nTitle:\nExecutive Vice President and Chief Financial Officer\n\nDated: June 29, 2026"}